屋檐管控制科特迪瓦媒介传播疾病:整群随机对照试验研究方案
本研究为双臂整群随机对照试验,在科特迪瓦评估In2Care®屋檐管(ET)对儿童临床疟疾发病率的影响,共纳入34个村庄(17个ET+长效杀虫蚊帐组,17个仅长效杀虫蚊帐组),每群随机选取55户有合格儿童的家庭进行主动检测,随访24个月,同时每月在20个群(10个ET群、10个对照群)进行昆虫学监测。
要点
- ET作为独立工具在已安装ET的房屋中评估对儿童临床疟疾发病率的影响。
- 34个村庄随机分为ET+LLIN组(17群)和仅LLIN组(17群),每群选55户有6月龄至8岁儿童的家庭。
- 干预和对照队列随访24个月,每月在20个群(10 ET、10对照)进行室内CDC诱蚊监测。
核心结论
- 研究结果将作为ET的功效试验提交给世界卫生组织病媒控制咨询组(VCAG)评估公共卫生价值。
- 昆虫学结局将作为疟疾传播的替代指标,帮助制定未来In2Care® ET产品的评估指南。
研究设计与样本
- 双臂、整群随机对照试验,在科特迪瓦评估ET对儿童临床疟疾发病率的影响。
- 根据人口规模和适合改造房屋的比例选择34个村庄,17个治疗组(ET+LLIN)和17个对照组(仅LLIN)。
- 每群根据人口普查随机选取55户有合格儿童(研究开始时6月龄至8岁)的家庭纳入主动检测队列。
- 治疗组纳入居住在ET处理房屋的合格儿童;干预和对照队列随访4个月进行基线协变量测量,随后干预随访24个月。
- 每月在20个群(10个ET群、10个对照群)每群随机选10户进行室内CDC诱蚊采样,并在部分蚊虫样本中检测子孢子率。
临床怎么用
- 病例检测访视时对所有发热儿童采血,用快速诊断试验(RDT)检测疟疾感染,所有阳性临床疟疾感染均予治疗。
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vector control tools, long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), have significantly contributed to malaria prevention efforts in sub-Saharan Africa. However, insecticide resistance has seriously hampered their efficacy in recent years and new tools are essential to further progress. In2Care® EaveTubes (ETs) are an inexpensive, new resistance-breaking vector control product under World Health Organization (WHO) evaluation informed by mosquito ecology to efficiently target malaria vectors. By installing ETs in the walls of the house at the eave level that funnel the natural airflow, mosquitoes are drawn in by the same heat and odor cues that typically attract them through open eaves. Once inside an ET, mosquitoes are exposed to insecticide-treated netting placed inside the ET. The aim of this study is to test whether ETs as stand-alone tool have an effect on the epidemiology of malaria in villages where houses have been modified with the ET intervention. METHODS: A two-armed, cluster randomized controlled trial will be conducted to evaluate the effect of ETs on clinical malaria incidence in children living in Côte d'Ivoire. Thirty-four villages will be selected based on population size and the proportion of houses suitable for modification with ETs (17 treatment arms (ETs + LLINs, 17 control arms (LLINs only)). Based on the population census, 55 households per cluster with eligible children (i.e., between the ages of 6 months to 8 years old at the start of the study) will be randomly selected for recruitment into the active detection cohorts. In the treatment arm, we will enroll eligible children who reside in ET-treated houses. The intervention and control cohorts will be followed for 4 months for baseline covariate measurements and 24 months with intervention. During case detection visits, blood samples will be taken from all febrile children and tested for malaria infection with rapid diagnostic tests (RDTs). All positive clinical malaria infections will be treated. To estimate the impact of the ET on malaria vector densities, entomological measurements (indoor sampling with CDC traps) will be conducted monthly in 20 clusters (10 ET, 10 Control) in 10 randomly selected households per cluster. To estimate the infectiousness of malaria vectors, sporozoite rates will be measured in subsets of the collected mosquito samples. DISCUSSION: Findings will serve as an efficacy trial of ETs and will be submitted to the WHO Vector Control Advisory Group (VCAG) for assessment of public health value. Entomological outcomes will also be measured as proxies of malaria transmission to help develop guidelines for the evaluation of future In2Care® ETs products. TRIAL REGISTRATION: ClinicalTrials.gov NCT05736679. Registered on 10 February 2023.
引用
- N'Guessan R, Assi SB, Koffi A, et al. EaveTubes for control of vector-borne diseases in Côte d'Ivoire: study protocol for a cluster randomized controlled trial. Trials. 2023. PMID: 37919815. doi:10.1186/s13063-023-07639-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。